Amna Batool
Rheumatology · Lexington, KYNPI 1952751703
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.4% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 39.5% of the total. That places this record below the midpoint for rheumatology clinicians in KY, where the typical reported total is $2,001.
Across 101 payments — averaging $19.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$789
- Novartis$300
- Johnson & Johnson$268
- AstraZeneca$181
- Amgen$148
- UCB, Inc.$72
- plus $242 from 10 others
What the payments were for
- Food & beverage$1,88894%
- Education$1136%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 52 | $789 |
| Novartis | 17 | $300 |
| Johnson & Johnson | 5 | $268 |
| AstraZeneca(2 entities) | 4 | $181 |
| Amgen(2 entities) | 8 | $148 |
| UCB, Inc. | 3 | $72 |
| E.r. Squibb & Sons, L.L.C. | 2 | $53 |
| Mallinckrodt Hospital Products Inc. | 1 | $39 |
| Pfizer | 2 | $34 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| Fresenius Kabi USA, LLC | 1 | $15 |
| GSK | 1 | $15 |
| Radius Health, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,001 in reported general payments places this provider in the 50th percentile of 81 rheumatology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 16 | $80,116 |
| Actemra ActpenTocilizumab | 16 | $68,883 |
| Hydroxychloroquine Sulfate | 138 | $4,702 |
| Leflunomide | 42 | $3,787 |
| MethotrexateMethotrexate Sodium | 97 | $2,781 |
| Sulfasalazine | 29 | $1,385 |
| Colchicine | 18 | $1,132 |
| Diclofenac Sodium | 21 | $757 |
| Duloxetine Hcl | 27 | $446 |
| Allopurinol | 29 | $434 |
| Prednisone | 93 | $338 |
| Cyclobenzaprine Hcl | 36 | $241 |
| Folic Acid | 11 | $201 |
| Gabapentin | 16 | $127 |
| Alendronate Sodium | 23 | $86 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Lexington
- Alexander BrownLexington$10K
- Kelly ColeLexington$9K
- Paramarajan PiranavanLexington$8K
- Elaine AlexanderLexington$8K
- Lucia HardiLexington$7K
- Izabela AnticLexington$5K
- Corey HatfieldLexington$4K
- Syed Haider AbbasLexington$3K
- Jeffrey NealLexington$3K
- Robert LightfootLexington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.